| Apixaban versus warfarin in patients with atrial fibrillation CB Granger, JH Alexander, JJV McMurray, RD Lopes, EM Hylek, ... New England Journal of Medicine 365 (11), 981-992, 2011 | 10490 | 2011 |
| Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure M Packer, PA Poole-Wilson, PW Armstrong, JGF Cleland, JD Horowitz, ... Circulation 100 (23), 2312-2318, 1999 | 1754 | 1999 |
| International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology JR Ghadri, IS Wittstein, A Prasad, S Sharkey, K Dote, YJ Akashi, ... European heart journal 39 (22), 2032-2046, 2018 | 1243 | 2018 |
| Effects of a multidisciplinary, home-based intervention on planned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study S Stewart, JE Marley, JD Horowitz The Lancet 354 (9184), 1077-1083, 1999 | 849 | 1999 |
| International expert consensus document on Takotsubo syndrome (part II): diagnostic workup, outcome, and management JR Ghadri, IS Wittstein, A Prasad, S Sharkey, K Dote, YJ Akashi, ... European Heart Journal 39 (22), 2047-2062, 2018 | 657 | 2018 |
| Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care S Stewart, S Pearson, JD Horowitz Archives of Internal Medicine 158 (10), 1067-1072, 1998 | 622 | 1998 |
| Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale RD Lopes, JH Alexander, SM Al-Khatib, J Ansell, R Diaz, JD Easton, ... American heart journal 159 (3), 331-339, 2010 | 586 | 2010 |
| Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial Apex AMI Investigators Jama 297 (1), 43-51, 2007 | 527 | 2007 |
| The coronary slow flow phenomenon–a new coronary microvascular disorder JF Beltrame, SB Limaye, JD Horowitz Cardiology 97 (4), 197-202, 2002 | 499 | 2002 |
| International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina E Topol, R Califf, F Van de Werf, R Diaz, E Paolasso, P Aylward, J Simes, ... Circulation 97 (24), 2386-2395, 1998 | 447 | 1998 |
| Home-based intervention in congestive heart failure: long-term implications on readmission and survival S Stewart, JD Horowitz Circulation 105 (24), 2861-2866, 2002 | 427 | 2002 |
| Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial BF Uretsky, K Thygesen, PW Armstrong, JG Cleland, JD Horowitz, ... Circulation 102 (6), 611-616, 2000 | 409 | 2000 |
| Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment L Lee, R Campbell, M Scheuermann-Freestone, R Taylor, P Gunaruwan, ... Circulation 112 (21), 3280-3288, 2005 | 403 | 2005 |
| Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure S Stewart, AJ Vandenbroek, S Pearson, JD Horowitz Archives of internal medicine 159 (3), 257-261, 1999 | 380 | 1999 |
| Metabolic manipulation in ischaemic heart disease, a novel approach to treatment L Lee, J Horowitz, M Frenneaux European heart journal 25 (8), 634-641, 2004 | 368 | 2004 |
| Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for … L Wallentin, Z Hijazi, U Andersson, JH Alexander, R De Caterina, ... Circulation 130 (21), 1847-1858, 2014 | 309 | 2014 |
| Systematic review and meta-analysis of incidence and correlates of recurrence of takotsubo cardiomyopathy K Singh, K Carson, Z Usmani, G Sawhney, R Shah, J Horowitz International journal of cardiology 174 (3), 696-701, 2014 | 284 | 2014 |
| Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial L Rydén, PW Armstrong, JGF Cleland, JD Horowitz, BM Massie, M Packer, ... European heart journal 21 (23), 1967-1978, 2000 | 279 | 2000 |
| Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. JD Horowitz, EM Antman, BH Lorell, WH Barry, TW Smith Circulation 68 (6), 1247-1253, 1983 | 267 | 1983 |
| Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon JF Beltrame, SB Limaye, RD Wuttke, JD Horowitz American heart journal 146 (1), 84-90, 2003 | 264 | 2003 |
Thanh Ha NguyenUniversity of AdelaideE-mail megerősítve itt: adelaide.edu.au
